Company · CIK 0000730272
REPLIGEN CORP
RGENSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$169.82+$5.98 (+3.65%)
RGEN · Last trade
- Prev close
- $163.84
- Range (30d)
- $163.84 – $194.57
On the record
Recent filings
- SCHEDULE 13G/ARGENREPLIGEN CORP0000315066-26-002329 · 11.7 KBSEC(opens sec.gov)
- 8-KRGENCurrent report0001193125-26-415015 · 179.8 KBSEC(opens sec.gov)
- 144RGENREPLIGEN CORP0001959173-26-007273 · 7.1 KBSEC(opens sec.gov)
- 144RGENREPLIGEN CORP0001959173-26-007257 · 7.1 KBSEC(opens sec.gov)
- 144RGENREPLIGEN CORP0001959173-26-007110 · 6.3 KBSEC(opens sec.gov)
- 144RGENREPLIGEN CORP0001959173-26-007059 · 5.8 KBSEC(opens sec.gov)
- 8-KRGENCurrent report0001628280-26-062043 · 138.8 KBSEC(opens sec.gov)
- 8-KRGENCurrent report0001193125-26-385380 · 151.0 KBSEC(opens sec.gov)
- 144RGENREPLIGEN CORP0001959173-26-006730 · 5.2 KBSEC(opens sec.gov)
- 144RGENREPLIGEN CORP0001959173-26-006257 · 4.5 KBSEC(opens sec.gov)
Insiders
- ARIES DOMESTIC FUND L P10% Owner
- ARIES FINANCIAL SERVICES INCInsider
- ARIES TRUSTInsider
- BARTHELEMY NICOLASDirector
- Benjamin HowardVP Business Development
- BIOTECHNOLOGY VALUE FUND L PDirect Beneficial Owner
- BVF INC/IL10% Owner, Indirect Beneficial Owner
- BVF PARTNERS L P/IL10% Owner, Indirect Beneficial Owner
- Bylund JamesChief Operating Officer
- COOPER GLENN L MDDirector
Tickers
Addresses
business
41 SEYON STREET BUILDING 1, SUITE 100
WALTHAM, MA, 02453
mailing
41 SEYON STREET BUILDING 1, SUITE 100
WALTHAM, MA, 02453
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies